These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 2852190)

  • 21. [Co-occurring liver cell adenoma and focal nodular hyperplasia due to contraceptives. Case report].
    Reichlin B; Stalder GA; Rüedi T; Bianchi L
    Schweiz Med Wochenschr; 1980 May; 110(22):873-4. PubMed ID: 6250211
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Sex hormones and hepatic neoplasia.
    Goldfarb S
    Cancer Res; 1976 Jul; 36(7 PT 2):2584-8. PubMed ID: 179705
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Benign hepatocellular tumors.
    Guzman IJ; Gold JH; Rosai J; Schneider PD; Varco RL; Buchwald H
    Surgery; 1977 Oct; 82(4):495-503. PubMed ID: 197654
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Focal nodular hyperplasia, hepatocellular adenoma and hormonal contraceptives].
    Corboz A
    Schweiz Rundsch Med Prax; 1983 Feb; 72(6):177-82. PubMed ID: 6300822
    [No Abstract]   [Full Text] [Related]  

  • 25. [Benign tumours of the liver and oral contraceptives (author's transl)].
    Lesbros F; Beurlet J; Berger F; Courtieu M
    Arch Anat Cytol Pathol; 1980; 28(1):24-31. PubMed ID: 7377845
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Liver oncogenesis and steroids.
    Christopherson WM; Mays ET; Barrows GH
    Prog Clin Cancer; 1978; 7():153-63. PubMed ID: 212780
    [TBL] [Abstract][Full Text] [Related]  

  • 27. NTP Toxicology and Carcinogenesis Studies of o-Nitroanisole (CAS No. 91-23-6) in F344 Rats and B6C3F1 Mice (Feed Studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 1993 May; 416():1-482. PubMed ID: 12616295
    [TBL] [Abstract][Full Text] [Related]  

  • 28. NTP Toxicology and Carcinogenesis of 1,2,3-Trichloropropane (CAS No. 96-18-4) in F344/N Rats and B6C3F1 Mice (Gavage Studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 1993 Aug; 384():1-348. PubMed ID: 12692652
    [TBL] [Abstract][Full Text] [Related]  

  • 29. NTP Toxicology and Carcinogenesis Studies of Benzene (CAS No. 71-43-2) in F344/N Rats and B6C3F1 Mice (Gavage Studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 1986 Apr; 289():1-277. PubMed ID: 12748714
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Benign liver tumors: what is their relationship to oral contraceptives?
    Lansing PB; McQuitty JT; Bradburn DM
    Am Surg; 1976 Oct; 42(10):744-60. PubMed ID: 184729
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Oral contraceptives and benign tumors of the liver.
    Fitz JG
    West J Med; 1984 Feb; 140(2):260-7. PubMed ID: 6730471
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Hepatic adenoma and focal nodular hyperplasia: clinical, pathologic, and radiologic features.
    Kerlin P; Davis GL; McGill DB; Weiland LH; Adson MA; Sheedy PF
    Gastroenterology; 1983 May; 84(5 Pt 1):994-1002. PubMed ID: 6299876
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Two cases of benign liver tumour in women on oral contraceptives (author's transl)].
    Dauplat J; Gauthier JP; Fonck Y; Bruhat M; Giraud B
    J Chir (Paris); 1979 Nov; 116(11):651-7. PubMed ID: 555770
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Role of oral contraceptive agents in the pathogenesis of liver tumors.
    Nissen ED; Kent DR; Nissen SE
    J Toxicol Environ Health; 1979; 5(2-3):231-54. PubMed ID: 224197
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Estrogen and progesterone receptors in human liver: does their study contribute to a better understanding of benign contraceptive-associated liver tumors?].
    Pirovino M; Wälti E; Akovbiantz A; Arrenbrecht S; Zava D; Bühler H; Schmid M
    Schweiz Med Wochenschr; 1986 Jul; 116(29):971-3. PubMed ID: 3020682
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Focal nodular hyperplasia and liver cell adenoma: operation or observation?].
    Ott R; Hohenberger W
    Zentralbl Chir; 1998; 123(2):145-53. PubMed ID: 9556887
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Survey of primary liver tumors and oral contraceptive use.
    Vana J; Murphy GP; Aronoff BL; Baker HW
    J Toxicol Environ Health; 1979; 5(2-3):255-73. PubMed ID: 224198
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A clinicopathologic study of steroid-related liver tumors.
    Christopherson WM; Mays ET; Barrows G
    Am J Surg Pathol; 1977 Mar; 1(1):31-41. PubMed ID: 203201
    [TBL] [Abstract][Full Text] [Related]  

  • 39. NTP Toxicology and Carcinogenesis Studies of Methyleugenol (CAS NO. 93-15-2) in F344/N Rats and B6C3F1 Mice (Gavage Studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 2000 Jul; 491():1-412. PubMed ID: 12563349
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Benign liver tumors and oral contraceptives--difficulties in diagnosis].
    Hintsche-Kilger BB; Fengler JD; Binus R; Baumgarten R
    Z Arztl Fortbild (Jena); 1991 Jun; 85(11):513-5. PubMed ID: 1654677
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.